Free Submission Public Relations &
Deutsch English


Elona Baum at to Speak at Stem Cell Summit (Apr 23-25, 2014 - Cambridge, MA)

Print article Print article
2014-02-03 06:57:35 - Elona Baum from California Institute for Regenerative Medicine to Present at Stem Cell Summit 2014 (Apr 23-25, 2014 in Cambridge, MA)

Elona Baum from California Institute for Regenerative Medicine, will give a presentation on funding opportunities at the Stem Cell Summit 2014 to be held on April 23-25, 2014 in Cambridge, MA.

Elona Baum is the General Counsel and VP of Business Development for the California Institute for Regenerative Medicine (CIRM). She is a member of CIRM’s executive team and is responsible for the agency’s legal functions and strategic initiatives which include building industry alliances, structuring CIRM’s co-funding initiatives and FDA engagement. From 1996 to 2009, Ms. Baum held the positions of Associate General Counsel, and Director of Regulatory Policy and Strategy at Genentech, Inc. She also served as the Secretary to the Board of Directors of Genentech Espana.

The Stem Cell

Summit 2014 includes two conferences including joint sessions. This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and commercialization of stem cells.

Conference A: Stem Cell Research & Regenerative Medicine:
Advances in Adult & Pluripotent Stem Cells
New Paradigms in Cell Therapy
Tissue Engineering
Cells for Drug Discovery & Diagnostics

Conference B: Stem Cell Commercialization & Partnering:
Novel Technologies in Stem Cell Research
Overcoming Challenges in Clinical Development
Commercialization: Bringing Therapeutics to Market
Panel Discussion: Strategic Partnering

Joint Sessions:
Regulatory Guidance & Updates
Funding Opportunities

For more information, please visit

Contact Information:

635 W. Foothill Blvd. Monrovia, CA 91016

Contact Person:
Kristen Starkey

Phone: 6262566405
email: email


Rania hafez
Phone: 626-256-6405

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact